Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2

Different homologous and heterologous vaccination regimens have been used for COVID-19. Here the authors show in a cohort analysis from Catalonia that heterologous vaccination with ChAdOx1 followed by BNT162b2 has better vaccine effectiveness than two doses of ChAdOx1.

Bibliografiske detaljer

Principais autores:	Eduardo Hermosilla, Ermengol Coma, Junqing Xie, Shuo Feng, Carmen Cabezas, Leonardo Méndez-Boo, Francesc Fina, Elisabet Ballo, Montserrat Martínez, Manuel Medina-Peralta, Josep Maria Argimon, Daniel Prieto-Alhambra
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Portfolio 2022-03-01
Serier:	Nature Communications
Online adgang:	https://doi.org/10.1038/s41467-022-29301-9
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!